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Migraine has a substantial impact on health-
related quality of life (HRQoL) and has become an
important health issue because of the resulting dis-
ability.1 In Taiwan, the prevalence of migraine is
9.1%, which is comparable but in the lower range
of the Western headache series (8–15%).2 Because
prevalence peaks during the most productive
years, migraine is an important cause of lost
work time. Studies conducted in Western countries
consistently showed that about three-quarters of
migraine sufferers had a reduced ability to function
during migraine episodes.3,4 The World Health
fOrganization recognized severe migraine as one o
the top 20 disabling disorders in the world.5 While
epidemiologic studies and comorbid depressive
and anxiety disorders have been well studied,2,6
there has been little study of characteristics of the
disability in migraine sufferers in Taiwan.
The US Headache Consortium Guidelines
emphasize the importance of assessing headache-
related disability in the management of migraine,
and the need to tailor treatment for patients
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Background/Purpose: The seven-item Migraine Disability Assessment (MIDAS) questionnaire is a simple
and useful tool for evaluating migraine-related disability. The goals of this study were: (1) to test the relia-
bility and validity of the Taiwan version of the MIDAS (MIDAS-T) questionnaire, and (2) to measure the
impact of migraine among Taiwanese patients in a headache clinic.
Methods: Consecutive migraine patients, aged 20–50 years, visiting the headache clinic at the Taipei
Veterans General Hospital were invited to participate in the study. They completed the MIDAS-T and a
fform, which collected headache-related information including characteristics and impact on their lives. O
them, about 30 patients were randomly invited to repeat the MIDAS-T 3 weeks later.
Results: A total of 281 migraine patients (M/F, 63/218; mean age, 35.27 ± 8.21 years) participated in the
study. Of them, 31 completed the MIDAS-T again 3 weeks later. MIDAS-T showed acceptable internal con-
sistency (Cronbach α = 0.79), test–retest reliability (r = 0.67) and criterion validity (r = A0.37 for question 
[headache frequency] and r=0.34 for question B [headache intensity], p<0.001). The mean score of migraine
patients on MIDAS-T was 34.21 ± 45.90, ranging from 0 to 265. MIDAS grade I (score 0–5) was found in 22%
of patients, grade II (6–10) in 15%, grade III (11–20) in 17%, and grade IV (≥ 21) in 46%.
Conclusion: This study supports the reliability and validity of MIDAS-T for use in Taiwanese patients.
Almost half of the migraine patients were classified as having severe disability (grade IV). [J Formos Med
Assoc 2006;105(7):563–568]
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through the development of individualized man-
agement plans.7 The three most frequently used
headache-specific outcome measures are the Mi-
graine Disability Assessment Score (MIDAS)
questionnaire,8,9 the Headache Impact Test
(HIT),10 and the Headache Disability Inventory
(HDI).11 All three questionnaires are easy for 
patients to complete; however, HIT and HDI are
more difficult to score than the MIDAS question-
naire. The MIDAS questionnaire was first re-
ported in 1999. It is a seven-item questionnaire
that is designed to assess the impact of migraine
on school work, paid work, household work,
and family, social, or leisure activities over the
past 3 months.8,9 It is easy to score. Previous
studies showed that MIDAS has good reliability
and validity in the original English version8,9 as
well as in the Italian,12 Japanese,13 and Turkish
versions.14 Accordingly, MIDAS has become a
popular and useful tool for evaluating migraine-
related disability worldwide. A recent study
using MIDAS found that MIDAS scores were sub-
stantially higher in migraine cases than in non-
migraine cases.15
The results of the MIDAS scores can be
grouped into four disability grades: grade I (mini-
mal or infrequent disability), grade II (mild or 
infrequent disability), grade III (moderate dis-
ability), and grade IV (severe disability). A pre-
vious study suggested that incorporation of
MIDAS into the US Headache Consortium Guide-
lines facilitated the use of stratified care strategies
that were preferable to those obtained using the
conventional stepwise approach.16 Initial treat-
ment strategies can be adopted according to the
extent of disability measured by MIDAS. This is in
contrast to the previous practice in which initial
treatment was nonspecific. A MIDAS grade can
help physician–patient communication and can
be used easily in daily practice.
The aim of this study was to assess the
validity and reliability of the Taiwan version 
of the MIDAS (MIDAS-T) for migraine sufferers.
We also evaluated the impact of migraine in 




Consecutive new outpatients aged 20–50 years,
who visited the headache clinic of Taipei
Veterans General Hospital from April 2003 to
June 2004, were enrolled. Patients in this age
range were chosen because of the high preva-
lence of the condition in them. The original do-
mains of MIDAS were also developed using a
sample of this age group. Taipei Veterans General
Hospital is a 2198-bed medical center in Taiwan.
It serves both veterans and other citizens, and
most of the patients come from northern
Taiwan. The diagnosis of migraine was based on
the criteria of the fInternational Classification o
Headache Disorders, 2nd edition (ICHD-II), 2004.17
All participants were evaluated by a headache
specialist on their initial visit. All of them filled
cout a questionnaire, which collected demographi
data, characteristics of the headache (frequency,
severity presented on a verbal numerical scale
[0–10], associated symptoms), and headache im-
pact on daily life, work, and social activities.
They also completed the MIDAS-T question-
naire. The Institutional Review Board of Taipei
yVeterans General Hospital approved the stud
protocol.
MIDAS-T questionnaire
MIDAS is a seven-item self-administered ques-
tionnaire (Table 1).8,9  The first five questions
assess the influence of headache on three domains
of activity over the preceding 3 months, and each
gof these items can have possible scores rangin
from 0 to 90. The other two questions (A and B)
were designed to provide the physician with clin-
ically relevant information on headache fre-
quency and pain intensity, and were not scored.
The MIDAS score was obtained by totaling the
scores for answers to the first five questions,
ranging from 0 to 270.
Four disability grades were assigned based on
gthe total score: grade I, total score 0–5, indicatin
minimal or infrequent disability; grade II, total
score 6–10, mild or infrequent disability; grade III,
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total score 11–20, moderate disability; grade IV,
total score 21 or more, severe disability.15
The MIDAS questionnaire was translated into
Chinese for use in Taiwan (MIDAS-T) following
the standard technique for cross-cultural research:
translation, back translation, and bilingual expert
panel evaluation.
Statistical analysis
All data were analyzed using SPSS version 11
(SPSS Inc, Chicago, IL, USA). For the analysis of
test–retest reliability, 31 patients were asked to
complete a second MIDAS-T 3 weeks after the
initial evaluation. The response data to individ-
ual MIDAS-T questions and the overall MIDAS-T
score were skewed towards higher values; there-
fore, Spearman rank correlation was used in the
assessment of test–retest reliability. The internal
consistency of the MIDAS-T score was assessed
using Cronbach α. An α of 0.7 was considered
acceptable; an α of 0.8 or greater was considered
to indicate excellent internal consistency.18 The
validity of MIDAS-T was assessed using crite-
rion validity by comparing figures for the total
MIDAS-T score with questions A (headache
frequency) and B (headache intensity) in the
MIDAS-T questionnaire, and other data collected
at enrollment. A p value of less than 0.05 was
regarded as the level of statistical significance.
Results
Demographic characteristics
During the study period, a total of 1070 consecu-
tive new patients (353 males, 717 females; mean
age, 47.24 ± 17.51 years) visited our headache
clinic. Of them, 315 (29.4%) patients who were
between 20 and 50 years old and had a diagnosis
of migraine agreed to participate in the study.
 They completed the MIDAS-T questionnaire,
the data collection form on demographics and
headache characteristics, and underwent evalua-
tion by a headache specialist. We excluded 24
rpatients who had incomplete data on thei
yMIDAS-T and 10 patients with contradictor
MIDAS-T answers (for example, the answers to
questions 1 and 2 or 3 and 4 were each more
than 90 days), yielding a final sample of 281 sub-
jects (89.21%). Table 2 summarizes the demo-
ygraphic and headache characteristics of the stud
patients. Most of the patients were female and
suffered from migraine without aura (93.95%).
More than 60% of them had a paid job; 49
women (17.43%) were homemakers and 17 pa-
tients (6.05%) were students. Of the 281 pa-
tients, 31 (6 men, 25 women; mean age, 34.8 ±
t9.8 years) agreed to participate in the test–retes
reliability study and completed another MIDAS-
T within 3 weeks.
MIDAS questionnaire—Taiwan version
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Table 1. MIDAS questionnaire
Instructions: Please answer the following questions about ALL the headaches you have had over the last 3 months. Write your
answer in the box next to each question. Write zero if you did not do the activity in the last 3 months. (Please refer to the calendar
below, if necessary.)
1. On how many days in the last 3 months did you miss work or school because of your headaches?  days
2. How many days in the last 3 months was your productivity at work or school reduced by half or more because of 
your headaches (do not include days you counted in question 1 where you missed work or school)?  days
3. On how many days in the last 3 months did you not do household work because of your headaches?  days
4. How many days in the last 3 months was your productivity in household work reduced by half or more because of 
your headaches (do not include days you counted in question 3 where you did not do household work)?  days
5. On how many days in the last 3 months did you miss family, social or leisure activities because of your headaches?  days
A. On how many days in the last 3 months did you have any headache (if a headache lasted more than 1 day, count  days
each day)?
B. On a scale of 0–10, on average how painful were these headaches (0=no pain at all, and 10=pain is as bad as it can be)? 
Innovative Medical Research, Inc.8,9
Reliability
Cronbach α, a measure of internal consistency,
was 0.79 for MIDAS-T in all study patients. Among
the 31 patients who finished the repeated exami-
nations, the test–retest reliability of individual
questions ranged from 0.48 (item 1: days missed
from family, social or leisure activities) to 0.73
t(item 5: days missed from work/school) and tha
of the total MIDAS-T score was 0.67 (by Spearman
correlation test) (Table 3).
Criterion validity
TThe correlation coefficients for the MIDAS-
score with question A (total number of headache
ydays) and with question B (headache severit
presented by verbal numerical scale) were 0.37
(p < 0.001) and 0.34 (p < 0.001), respectively. The
correlation coefficient of the MIDAS-T scores
with questions on the headache data collection
form (number of days of missed work or school
because of headache in the past 1 year) was 0.45
(p < 0.001).
MIDAS-T mean score and grade distributions
Table 3 shows the mean score for each item and
the total MIDAS-T score for migraine patients.
The mean score was 34.21, with a range from 0
to 265. Thirty-three patients scored zero. The
quartile scores were 6 for the 25th percentile
(Q1), 17 for the 50th rpercentile (Q2), and 42 fo
the 75th percentile (Q3). Ninety percent of pa-
Ttients scored less than 80. Based on the MIDAS-
disability grades, 63 patients (22.3%) had grade
I disability, 42 (15.0%) grade II, 47 (16.8%)
grade III, and 129 (45.9%) grade IV.
P.H. Hung, et al
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Table 2. Demographic and headache profile characteristics of 
281 patients with migraine
Characteristics Range
Mean age, yr 35.27 ± 8.21 20–50
Female, n (%) 218 (77.58)
Educational level, n (%)
Elementary school 23 (8.18)
Middle school 31 (11.03)
High school 92 (32.75)
University or college 121 (43.06)
Postgraduate 14 (4.98)
Married, n (%) 169 (60.14)
Paid job, n (%) 187 (66.55)
Mean duration of migraine (yr) 12.92 ± 8.42 0–42
Diagnosis of headache, n (%)
Migraine with aura 17 (6.05)
Migraine without aura 264 (93.95)
Migraine frequency (d/3 mo)
(Question A in MIDAS-T) 34.22 ± 29.42 0–90
Mean headache intensity (0–10 scale)
(Question B in MIDAS-T) 6.72 ± 2.02 1–10
MIDAS-T = Migraine Disability Assessment Questionnaire – Taiwan Version.
Table 3. Mean individual items and total MIDAS-T score and Spearman correlation coefficients for test–retest reliability
Test–retest reliability (n = 31)
Mean score of
Initial Repeat Spearman’s 
Question item
total sample 
MIDAS-T MIDAS-T correlation(n = 281)
score score coefficient(SD) (range)
mean (SD) mean (SD) (p)
1. Days missed from work/school 4.60 (9.86) (0–90) 4.16 (7.22) 2.82 (5.80) 0.73 (< 0.001)
2. Reduced effectiveness days at work/school 8.17 (12.20) (0–86) 6.68 (8.11) 12.68 (16.19) 0.63 (< 0.001)
3. Days missed from housework 7.09 (13.97) (0–90) 3.06 (4.42) 2.82 (4.72) 0.53 (0.02)
4. Reduced effectiveness in housework 8.03 (12.06) (0–90) 4.16 (5.33) 5.29 (7.35) 0.51 (0.003)
5. Days missed from family, social or leisure activities 6.51 (13.94) (0–90) 3.19 (4.01) 5.00 (8.69) 0.48 (0.06)
Total MIDAS-T score 34.21 (45.90) (0–265) 21.26 (23.00) 28.60 (27.10) 0.674 (< 0.001)
MIDAS-T = Migraine Disability Assessment Questionnaire – Taiwan version.
Discussion
The MIDAS questionnaire has become one of the
most important instruments for migraine impact
assessment and management.8,9,12–14 The pres-
ent study examining the reliability and validity
of the MIDAS-T version were favorable. In the
studies of the original English and other lan-
guage versions of MIDAS, the test–retest Pearson
or Spearman correlation coefficients ranged from
0.68 to 0.84 and the Cronbach α of internal con-
sistency of the MIDAS score was 0.7–0.84. The
reliability of MIDAS-T in this study is compara-
ble to those reported in studies of the original
English and other language versions of this 
instrument.8,9,12–14
The test–retest correlation coefficients for
household chores and for family, social and
leisure activities were lower compared with those
for paid work or school. This result might be due
to the fact that paid work or school is usually
more stable activities than family, social and
leisure activities; therefore, the number of days
missed for paid work or for school is more easily
recalled by patients. The mean MIDAS-T scores for
total days of paid work and housework missed
were decreased, but the mean MIDAS-T scores for
days of paid work and housework with a loss of
more than 50% efficacy were increased. The rea-
sons for why patients’ headaches improved at the
repeat test were not clear. There are at least two
possible explanations, however. First, the patients’
headaches might have improved after medical 
advice or treatment obtained at their first visit.
Second, this result might just reflect “regression to
the mean”, i.e., the disability was most severe
when the patients sought medical advice, and
their headaches gradually recovered afterward.
As with previous studies on MIDAS,8,19 we
found that the number of days of reduced produc-
tivity was greater than the total number of days
lost. This implies that many migraine patients
may feel that it is necessary to suffer from pain
without taking any sick leave from work, even
though their work efficacy is poor. Our results also
showed that more days of housework were missed
than those of nonwork activity (family, social,
leisure) followed by the number of work days.
cPatients with migraine in our headache clini
suffered from a high level of functional disability.
The mean score of MIDAS-T was 34.3, which was
higher than the cutoff score (≥ 21) for the grade
of severe disability (grade IV). Even though the
50th percentile of the MIDAS-T score was 17,
47% of patients with migraine had severe disabi-
lity (grade IV, ≥ T21) according to their MIDAS-
scores in this survey. Therefore, on average, mi-
graine patients in this study had suffered from
very severe disability in the past 3 months before
visiting the headache clinic.
The American DISC study suggested that pa-
tients with MIDAS grade II, III or IV would bene-
fit from structured medical treatment.15 This
group of patients comprised 78% of our clinical
tsample in this study, which suggests that mos
tpatients seen in a clinical setting would benefi
from stratified care strategies rather than the
usual step care program. Many patients with
tmigraine seen at neurologic services should star
migraine-specific treatment, either using abortive
y(such as triptans) or prophylactic agents as earl
as possible.
There were several important limitations to this
study. First, the MIDAS questionnaire has been
criticized regarding its domain designations.10
yAlthough inability to work is likely to be highl
correlated with inability to do housework and to
participate in social and family activities, these are
treated as separate domains in this questionnaire.
yTherefore, a single day of disabling headache ma
contribute more than 1 point to the total score. In
addition, a 50% reduction in capacity is scored the
ysame as complete inability to perform. The slightl
ylonger period of assessment (90 days) for memor
might introduce recall bias.20 tAll these inheren
tlimitations might bias the measure of the impac
due to headaches. Further, as this study was con-
ducted in the headache clinic of a medical center,
one should be cautious in generalizing the find-
tings to other patient populations in differen
fclinical settings. For example, the frequency o
migraine with aura (5.6%) in this study was
MIDAS questionnaire—Taiwan version
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lower when compared with the proportions
(10.7–46.6%) of patients having migraine with
aura in other Asian epidemiologic surveys.2 This
low frequency probably resulted from sampling
bias because patients with migraine without aura
usually suffer from more severe disability.
In conclusion, this study demonstrated that
MIDAS-T is a reliable, valid, and migraine-specific
tool to assess headache-related disability in
Taiwanese patients. We also found a high preva-
lence of disability (grade IV) among migraine
patients in our headache clinic. This simple
seven-item questionnaire is applicable as a tool
to assess and treat migraine patients in Taiwan.
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